Gradient Investments LLC Regeneron Pharmaceuticals, Inc. Transaction History

Gradient Investments LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$883.2 - $1071.19 $883 - $1,071	-1 Reduced 10.0%	9 $9,000
Q1 2024 Apr 23, 2024	SELL	$902.69 - $993.35 $5,416 - $5,960	-6 Reduced 37.5%	10 $9,000
Q3 2023 Oct 27, 2023	SELL	$692.45 - $844.37 $692 - $844	-1 Reduced 5.88%	16 $13,000
Q2 2023 Jul 11, 2023	BUY	$700.03 - $830.35 $2,800 - $3,321	4 Added 30.77%	17 $12,000
Q1 2023 Apr 17, 2023	SELL	$680.49 - $826.97 $680 - $826	-1 Reduced 7.14%	13 $10,000
Q2 2022 Jul 11, 2022	BUY	$548.35 - $738.84 $1,645 - $2,216	3 Added 27.27%	14 $8,000
Q1 2021 Apr 21, 2021	SELL	$446.73 - $548.2 $446 - $548	-1 Reduced 8.33%	11 $5,000
Q3 2020 Oct 06, 2020	BUY	$544.75 - $658.21 $2,723 - $3,291	5 Added 71.43%	12 $7,000
Q2 2020 Jul 10, 2020	BUY	$493.32 - $643.92 $493 - $643	1 Added 16.67%	7 $4,000
Q4 2019 Jan 15, 2020	BUY	$274.13 - $376.51 $548 - $753	2 Added 50.0%	6 $2,000
Q3 2019 Oct 10, 2019	BUY	$273.46 - $318.39 $1,093 - $1,273	4 New	4 $1,000
Q2 2018 Aug 09, 2018	SELL	$284.6 - $344.99 $284 - $344	-1 Closed	0 $0
Q1 2018 Apr 11, 2018	SELL	$315.82 - $393.78 $947 - $1,181	-3 Reduced 75.0%	1 $0
Q4 2017 Feb 07, 2018	BUY	$358.63 - $469.95 $1,434 - $1,879	4	4 $2,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.